Newsroom
October 27, 2021
Bioventus to Release Third Quarter of Fiscal Year 2021 Financial Results on November 9, 2021
DURHAM, NC – October 27, 2021 – Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today…
October 26, 2021
Bioventus and Misonix Stockholders Approve the Acquisition of Misonix by Bioventus
DURHAM, NC and FARMINGDALE, NY – October 26, 2021 – Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for…
October 18, 2021
Bioventus Inc. and Misonix, Inc. Announce Election Deadline of 5:00 p.m. New York City Time, on October 25, 2021 for Misonix Stockholders to Elect Form of Merger Consideration
DURHAM, NC and FARMINGDALE, NY – October 18, 2021 –Bioventus Inc. (Nasdaq: BVS) and Misonix, Inc. (Nasdaq: MSON) (“Misonix”), today announced an…
September 20, 2021
DUROLANE Among High-Molecular Weight Hyaluronic Acid Treatments Linked to Significant Improvements in Knee Osteoarthritis Pain by American Academy of Orthopaedic Surgeons
DURHAM, NC – September 20, 2021 – Bioventus Inc., (Nasdaq: BVS) (“Bioventus” or the “Company”), a leader in innovations for active healing, announced…
August 30, 2021
Bioventus Proceeds with Option Structure Agreement with CartiHeal
DURHAM, NC – August 30, 2021 – Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, has…
August 25, 2021
Bioventus Invests in Trice Medical Minimally Invasive Technologies
Bioventus Also Agrees to OUS Distribution and Co-Development Relationships DURHAM, NC – August 25, 2021 – Bioventus Inc. (Nasdaq: BVS) (“Bioventus”…
August 23, 2021
Dave Crawford Joins Bioventus as Vice President, Investor Relations and Treasurer
DURHAM, NC – August 23, 2021 – Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, has…
August 10, 2021
Bioventus Reports Second Quarter Results; Updates Full Year 2021 Financial Guidance
DURHAM, NC – August 10, 2021 – Bioventus Inc. (Nasdaq: BVS) ("Bioventus" or "the Company"), a global leader in innovations for active healing, today…
July 29, 2021
Bioventus and Misonix Announce Definitive Agreement for Bioventus to Acquire Misonix
The Combination Further Differentiates Bioventus’ Product Portfolio and Accelerates Its Revenue Growth Significantly Expands TAM and Adds…
July 29, 2021
Bioventus Inc. Reports Preliminary Second Quarter Net Sales; Updates Full-Year 2021 Net Sales Guidance
DURHAM, NC – July 29, 2021 – Bioventus Inc. (Nasdaq: BVS) ("Bioventus" or "the Company"), a global leader in innovations for active healing, today…
